A rare cause of seizure with benign course in a child
How to cite this article: Ghosh K. A rare cause of seizure with benign course in a child. J Hematol Allied Sci. 2023;3:76-7. doi: 10.25259/JHAS_30_2023
A 7-year-old male diagnosed case of B-cell acute lymphoblastic leukemia, intermediate risk group, central nervous system Status 1, received the first dose of methotrexate (2 g/m2) as consolidation. Serum methotrexate level at 42 h was <0.1 mmol/L and leucovorin rescue was administered as per protocol. On day 5 of therapy, he developed generalized tonic-clonic seizures without associated with any fever. The patient was started on Inj levetiracetam. His hemogram showed hemoglobin 9.6 g/dL, total leukocyte count 2100/cumm (N35% L60% M9% E5%), and platelets 76,000/cumm. Biochemistry revealed normal results of renal and liver function tests; serum electrolytes were also within normal limits. A computed tomography scan of the brain revealed no abnormality. Magnetic resonance imaging revealed hyperintensities with diffusion restriction in the bilateral deep white matter region [Figure 1a and b]. A diagnosis of methotrexate-induced leukoencephalopathy (LE) was made based on clinical and characteristic radiological features. The patient became symptom-free by 2 days and methotrexate was omitted from further courses of consolidation. Common causes of seizures in a leukemic child include stroke, infections, metabolic abnormalities, or cancer itself. Methotrexate-induced LE should be kept in mind in any patient presenting with subacute-onset neurological features 3–11 days after intravenous or intrathecal methotrexate therapy.[1,2]
Sincere thanks to my parents Mr. Bholanath Ghosh and Mrs. Sucharita Ghosh.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflicts of interest.
Financial support and sponsorship